These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1954471)

  • 1. High potency factor VIII concentrates.
    BMJ; 1991 Oct; 303(6809):1061-2. PubMed ID: 1954471
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIII in hemophilia A: the Canadian experience.
    Blanchette VS
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B19 parvovirus withstands "super heating" in antihemophilic concentrates.
    Morfini M; Azzi A; Mannucci PM
    Thromb Haemost; 1996 Nov; 76(5):821. PubMed ID: 8950802
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation factor VIII concentrates and the marketplace.
    Lancet; 1988 Jul; 2(8601):42-3. PubMed ID: 2898643
    [No Abstract]   [Full Text] [Related]  

  • 5. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
    Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation and use of factor VIII concentrates in hemophilia].
    Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL
    Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112
    [No Abstract]   [Full Text] [Related]  

  • 7. [Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
    Yoshioka A
    Rinsho Ketsueki; 1988 May; 29(5):649-54. PubMed ID: 3145996
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro characteristics of highly purified factor VIII concentrates.
    Morfini M
    Ann Hematol; 1991 Sep; 63(3):123-5. PubMed ID: 1932286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S; Yorifuji H; Arai M; Fukutake K
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract]   [Full Text] [Related]  

  • 10. Supply and need of factor VIII concentrates.
    Britten A; Etzel F; Ala F; Carman C; Smit Sibinga C
    Haematologia (Budap); 1983; 16(1-4):109-20. PubMed ID: 6434377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transmission of hepatitis C by factor concentrates].
    Aguilar C; Lucía JF
    Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V
    Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
    Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM; Ménaché D; Roberts HR
    Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary clinical experience: pharmacokinetics and tolerance of a double-virus-inactivated factor VIII preparation.
    Martinowitz U
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S84-5. PubMed ID: 7495976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII solutions in pre-filled syringes.
    Peerlinck K; Arnout J; Vermylen J
    Lancet; 1992 Feb; 339(8788):303-4. PubMed ID: 1346301
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C and pasteurised factor VIII and IX concentrates.
    Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
    Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical characterization of a new pasteurized monoclonal antibody purified factor VIIIC.
    Hrinda ME; Feldman F; Schreiber AB
    Semin Hematol; 1990 Apr; 27(2 Suppl 2):19-24. PubMed ID: 2128854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.
    Mannucci PM; Zanetti AR; Colombo M; Chistolini A; De Biasi R; Musso R; Tamponi G
    Thromb Haemost; 1990 Oct; 64(2):232-4. PubMed ID: 2176748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.